ISCOMATRIX Adjuvant Induces Potent Humoral and Cellular Immune Responses

Strategic Insights -

According to a study published in Vaccine, researchers from Australia have found that ISCOMATRIX adjuvant is capable of inducing broad and potent humoral and cellular immune responses. The study, led by Martin J. Pearse and D. Drane at CSL Ltd, highlights the potential of ISCOMATRIX adjuvant in vaccine development, particularly in inducing strong antibody and T cell responses with lesser amounts of antigen. The researchers also found that ISCOMATRIX adjuvant can be used to induce mucosal immune responses, making it a promising candidate for vaccines.

Key Takeaways:

  • ISCOMATRIX adjuvant induces potent humoral and cellular immune responses, including strong antibody and T cell responses.
  • The adjuvant can be used to induce mucosal immune responses, making it a promising candidate for vaccines.
  • ISCOMATRIX adjuvant has a well-defined composition and a simple, robust manufacturing process.
  • The adjuvant has been tested in various animal models, including human and non-human primates, with successful induction of immune responses.
  • Both CD4+ and CD8+ T cell responses are induced with ISCOMATRIX adjuvant, with cytotoxic T lymphocyte responses being very long-lived.
  • ISCOMATRIX adjuvant has the potential to reduce the amount of antigen required for vaccine development.

Statistics:

  • 22: The issue number in which the research was published (Vaccine, 2004;22(19 Sp. Iss):2391-2395).
  • 19: The special issue number in which the research was published (Vaccine, 2004;22(19 Sp. Iss):2391-2395).
  • 2391-2395: The page numbers in which the research was published (Vaccine, 2004;22(19 Sp. Iss)).

Sources:

  • Pearse, M. J., Drane, D. (2004). ISCOMATRIX adjuvant: a potent inducer of humoral and cellular immune responses. Vaccine, 22(19 Sp. Iss): 2391-2395.
  • CSL Ltd. (Investigator). (2004). ISCOMATRIX adjuvant induces potent humoral and cellular immune responses. NewsRx.com & NewsRx.net.
  • Elsevier Science Ltd. (Publisher). The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, Oxon, England.